Trial of gaviscon in the treatment of gastro-oesophageal reflux of infancy.
D000464:Alginates / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008274:Magnesium / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use
D000464:Alginates; D001639:Bicarbonates; D000536:Aluminum Hydroxide; D012822:Silicon Dioxide; D008274:Magnesium